Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» KOMET-001
KOMET-001
Kura Oncology Provides Update on Phase 1b Study of KO-539 in Acute Myeloid Leukemia
BioSpace
Wed, 11/24/21 - 10:14 am
Kura Oncology
KOMET-001
KO-539
AML
patient deaths